April, 2024
April 2024
OncoDaily Dialogues #2 – Piotr Wysocki / Hosted by Roupen Odabashian
Nov 15, 2023, 19:26

OncoDaily Dialogues #2 – Piotr Wysocki / Hosted by Roupen Odabashian

We continue our series of “OncoDaily Dialogues”. This initiative by OncoDaily is designed to spotlight leaders in the field of oncology, sharing their stories of success, challenges, and life lessons.

Today, we are honored to host a renowned oncologist from Poland, professor Piotr J. Wysocki, who is the Head of the Clinical Oncology Department at University Hospital and Head of the Faculty of Oncology at Jagiellonian University-Medical College (Krakow), the Past-President of the Polish Society of Clinical Oncology, and the chair of the ASCO European Regional Council. He graduated from the University of Medical Sciences in Poznan, Poland in 2000, obtained Ph.D. in molecular biology (2000), and got board-certified in medical oncology in 2007. In 2012 he received the title of titular professor of medicine, which is a life-time title granted by President of the Republic of Poland. In addition he was trained at the Department of Molecular Biology at Roswell Park Cancer Institute Buffalo, NY (1997) and Department of Oncology at the Princess Margaret Hospital in Toronto, Canada (2008). During his medical carrier prof. Wysocki was a promoter of four PhDs and trained dozens of medical oncology residents. He is a lead author of national guidelines for the treatment of genitourinary tumors and coauthor of guidelines in breast cancer. Prof. Wysocki serves as an advisor for the Polish Ministry of Health in the process of the development of a national cancer strategy. Over the last decade prof. Wysocki established two early-phase clinical study units in Cracow and Szczecin. His areas of clinical expertise include systemic treatment of breast, gynecologic, and GU cancers and the development of original metronomic chemotherapy-based therapies (chemo-endocrine, chemo-targeted, and metronomic polychemotherapy) for the treatment of advanced, pretreated cancer patients. Scientific interests include the development and application of immunopheresis for the treatment of solid tumors and the mitigation of immune-related adverse events. Prof. Wysocki has performed first-in-human studies with therapeutic immunopheresis and developed clinical study protocols for studies on apheresis-based systemic treatment in various solid tumors. Over the last 15 years prof. Wysocki acted as principal investigator in >70, phase I-III international clinical studies in oncology conducted in Poland. Prof. Wysocki has published >100 peer-reviewed articles on translational, clinical, and preclinical cancer research. His educational activities involve lectures and online courses for oncologists, residents and medical students (Jagiellonian University, Poznan University of Medicine). His portfolio comprises >1000 lectures and presentations given during national and international meetings, webinars, and symposia over the last 20 years. Since 2023, he has become a member of the American Society of Clinical Oncology International Affairs Committee.

Our host is Dr. Roupen Odabashian, hematology/oncology fellow at Karmanos Cancer Institute in Detroit, USA. Beyond his clinical practice, Dr. Odabashian possesses an unwavering passion for delving into the intricacies of healthcare policy, regulations and Oncology. He understands the multifaceted nature of cancer as a medical condition and acknowledges the various stakeholders and regulatory bodies that influence the delivery and administration of cancer treatments. In alignment with this commitment, he has joined OncoDaily, where he plays a pivotal role in conducting interviews with Leaders of the Cancer world.

You may view the previous series through the link below:

OncoDaily Dialogues #1 – Harout Semerjian / Hosted by Roupen Odabashian